InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,223.47
(
0.18%
)
US TECH 100
17,691.80
(
0.29%
)
Dow Jones
39,533.42
(
0.37%
)
Brent Oil
82.78
(
-1.40%
)
Bitcoin
60,649.01
(
-3.81%
)
Post# of 251786
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: acgood post# 148302

Thursday, 09/06/2012 11:36:04 PM

Thursday, September 06, 2012 11:36:04 PM

Post# of 251786

The SNTA trial is not blinded. The company sure had the data in hand for weeks last time as they talked the stock from 4 to 8 w/ wall street analysts in June. No reason to believe anything different is happening this time.

Good points.

didn't show/discuss the subgroup data - are they reversing and considering phase 3 in all adeno? mentioned OS benefit in all adeno specifically this time

I don't think they had definitively ruled out Phase 3 including all adeno before, did they?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up